Enspryng 120 mg solution for injection in pre-filled syringe *

  • Company:

    Roche Registration GmbH
  • Status:

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

  • EDM (Click to Download)

    Important Safety Information for Patients using ENSPRYNG® ▼(Satralizumab) Patient Alert Card

    Risk Minimisation Materials